NCT06009991

N/AInterventional

Trials without FDA-defined phases, including trials of devices or behavioral interventions.

View on ClinicalTrials.gov ↗

Timeline

Start date: Jul 17, 2023
Primary completion: Sep 30, 2025
Completion date: Dec 31, 2025
First posted: Aug 24, 2023
Last posted: Sep 6, 2023
Enrollment: 1876
Arms / groups: 4 / —
Source: AACT · ctgov ingestion

Sponsors

Huazhong University of Science and TechnologyLead sponsor
Huazhong University of Science and TechnologyOverall official - principal investigator
Huazhong University of Science and TechnologyReponsible party - principal investigator
Nanjing UniversityCollaborator
Sichuan UniversityCollaborator
Wuhan UniversityCollaborator
Wuhan UniversityCollaborator
Capital Medical UniversityCollaborator
Fujian Medical UniversityCollaborator
Tianjin University of Traditional Chinese MedicineCollaborator
Jingzhou Central HospitalCollaborator
Shiyan Taihe HospitalCollaborator
People's Liberation Army of ChinaCollaborator
People's Hospital Of YichangCollaborator
Shanxi Bethune HospitalCollaborator

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.